Should I buy or sell Vicarious Surgical stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares. View RBOT analyst ratings or view top-rated stocks .

What is Vicarious Surgical's stock price target for 2024?

4 analysts have issued 1-year price objectives for Vicarious Surgical's shares. Their RBOT share price targets range from $0.40 to $1.00. On average, they expect the company's share price to reach $0.67 in the next twelve months. This suggests a possible upside of 131.5% from the stock's current price. View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts .

How have RBOT shares performed in 2024?

Vicarious Surgical's stock was trading at $0.3667 at the beginning of the year. Since then, RBOT shares have decreased by 21.5% and is now trading at $0.2880. View the best growth stocks for 2024 here .

When is Vicarious Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024. View our RBOT earnings forecast .

How can I listen to Vicarious Surgical's earnings call?

Vicarious Surgical will be holding an earnings conference call on Monday, April 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc (NYSE:RBOT) issued its earnings results on Monday, March, 4th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.05. During the same period in the prior year, the company posted ($0.16) EPS.

How do I buy shares of Vicarious Surgical?

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free RBOT Stock Alerts

$0.29

+0.01 (+3.23%)

(As of 04:38 PM ET)

Compare

Today's Range: $0.26
▼
$0.30
50-Day Range: $0.25
▼
$0.52
52-Week Range: $0.20
▼
$2.46

Volume: 357,848 shs
Average Volume: 645,065 shs
Market Capitalization: $50.62 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $0.67

Get Vicarious Surgical alerts:

Vicarious Surgical MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 131.5% Upside
$0.67 Price Target
Short Interest: Bearish
3.47% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$24,441 Sold Last Quarter
Proj. Earnings Growth: Decreasing
From ($0.39) to ($0.41) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.30 out of 5 stars

Medical Sector

723rd out of 911 stocks

Surgical Appliances & Supplies Industry

16th out of 18 stocks

3.0

Analyst's Opinion

Consensus Rating
Vicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Vicarious Surgical has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
3.47% of the outstanding shares of Vicarious Surgical have been sold short.
Short Interest Ratio / Days to Cover
Vicarious Surgical has a short interest ratio ("days to cover") of 8.9.
Change versus previous month
Short interest in Vicarious Surgical has recently increased by 5.72%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Vicarious Surgical does not currently pay a dividend.
Dividend Growth
Vicarious Surgical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RBOT.

1.3

News and Social Media Coverage

News Sentiment
Vicarious Surgical has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.
Search Interest
Only 6 people have searched for RBOT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,441.00 in company stock.
Percentage Held by Insiders
14.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.39) to ($0.41) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Vicarious Surgical is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Vicarious Surgical is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Vicarious Surgical has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Behind the Markets

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

About Vicarious Surgical Stock (NYSE:RBOT)

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

RBOT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RBOT Stock News Headlines

April 19, 2024 | americanbankingnews.com

Vicarious Surgical (NYSE:RBOT) Trading 3.8% Higher

April 12, 2024 | msn.com

Robots in the operating room — and more

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

April 8, 2024 | businesswire.com

Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024

March 25, 2024 | hk.finance.yahoo.com

Insiders Give Up US$335k As Vicarious Surgical Stock Drops To US$0.34

March 23, 2024 | investing.com

Vicarious Surgical CTO sells shares worth over $1300

March 23, 2024 | investing.com

Vicarious Surgical CFO sells shares to cover tax obligations

March 20, 2024 | seekingalpha.com

RBOT Vicarious Surgical Inc.

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

March 12, 2024 | msn.com

Robotic interface masters a soft touch

March 7, 2024 | investing.com

Vicarious Surgical earnings beat by $0.06, revenue was in line with estimates

March 6, 2024 | seekingalpha.com

Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript

March 5, 2024 | au.finance.yahoo.com

Q4 2023 Vicarious Surgical Inc Earnings Call

March 5, 2024 | finance.yahoo.com

Vicarious Surgical Inc. (NYSE:RBOT) Q4 2023 Earnings Call Transcript

March 5, 2024 | markets.businessinsider.com

Vicarious Surgical (RBOT) Gets a Hold from BTIG

March 4, 2024 | marketwatch.com

Vicarious Surgical Chairman David Styka Resigns

March 4, 2024 | businesswire.com

Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results

February 22, 2024 | benzinga.com

Vicarious Surgical Stock (NYSE:RBOT), Short Interest Report

February 20, 2024 | finance.yahoo.com

Vicarious Surgical to Participate in TD Cowen’s 44th Annual Healthcare Conference

February 20, 2024 | businesswire.com

Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference

February 17, 2024 | finance.yahoo.com

RBOT Apr 2024 2.500 put

February 12, 2024 | finance.yahoo.com

Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

February 2, 2024 | msn.com

Surgical robot invented at UNL arrives at International Space Station

January 31, 2024 | msn.com

A Comprehensive Guide on Development to Impact of Surgical Robots

January 29, 2024 | msn.com

Vicarious Surgical appoints Randy Clark as President

January 29, 2024 | finance.yahoo.com

Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

December 28, 2023 | benzinga.com

Vicarious Surgical Stock (NYSE:RBOT) Dividends: History, Yield and Dates

See More Headlines

Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/04/2024
Today: 4/19/2024
Next Earnings (Confirmed): 4/29/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NYSE:RBOT
CUSIP: N/A
CIK: 1812173
Web: www.vicarioussurgical.com
Phone: 617 868 1700
Fax: N/A
Employees: 3
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $0.67
High Stock Price Target: $1.00
Low Stock Price Target: $0.40
Potential Upside/Downside: +127.8%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.49)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-71,070,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -82.61%
Return on Assets: -63.88%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 13.87
Quick Ratio: 13.87

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.56 per share
Price / Book: 0.52

Miscellaneous

Outstanding Shares: 175,750,000
Free Float: 149,864,000
Market Cap: $51.44 million
Optionable: Optionable
Beta: 1.18

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RBOT Stock Analysis - Frequently Asked Questions

Should I buy or sell Vicarious Surgical stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares.
View RBOT analyst ratings or view top-rated stocks.
What is Vicarious Surgical's stock price target for 2024?: 4 analysts have issued 1-year price objectives for Vicarious Surgical's shares. Their RBOT share price targets range from $0.40 to $1.00. On average, they expect the company's share price to reach $0.67 in the next twelve months. This suggests a possible upside of 131.5% from the stock's current price.
View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts.
How have RBOT shares performed in 2024?: Vicarious Surgical's stock was trading at $0.3667 at the beginning of the year. Since then, RBOT shares have decreased by 21.5% and is now trading at $0.2880.
View the best growth stocks for 2024 here.
When is Vicarious Surgical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024.
View our RBOT earnings forecast.

How can I listen to Vicarious Surgical's earnings call?: Vicarious Surgical will be holding an earnings conference call on Monday, April 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Vicarious Surgical's earnings last quarter?: Vicarious Surgical Inc (NYSE:RBOT) issued its earnings results on Monday, March, 4th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.05. During the same period in the prior year, the company posted ($0.16) EPS.
How do I buy shares of Vicarious Surgical?: Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:RBOT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial